|
|
Article: Gardasil prevents HPV, genital warts in males.(INFECTIOUS DISEASES)(Clinical report)
- Article from:
- Skin & Allergy News
- Article date:
- August 1, 2009
- Author:
CopyrightCOPYRIGHT 2009 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
ATLANTA -- Merck & Co.'s human papillomavirus vaccine Gardasil was efficacious against persistent infections and genital warts caused by the vaccine strains, in a randomized, double-blind, placebo-controlled study of more than 4,000 adolescent and young adult males.
The study, funded by Merck, was planned as a 36-month follow-up bur was stopped early based on efficacy and safety data at a mean of 29 months, according to Dr. Richard M. Haupt, executive director of clinical research, Merck Research Laboratories, Whitehouse Station, N.J. The company submitted a biologics licensing application to the Food and Drug Administration in December 2008 for the use of ...